Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company specializing in the development and commercialization of ...
At close: November 8 at 4:00 PM EST ...
Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.61 per share, missing the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.34 per share a year ago.
As we approach the Vivos Therapeutics, Inc. 2024 Annual Meeting of Stockholders on November 26, 2024 at 10:00 a.m. Mountain time, I am pleased to report the progress we have made over the past 12 ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Relay Therapeutics Inc ( (RLAY)) has released its Q3 earnings. Here is a breakdown of the information Relay Therapeutics Inc presented to its investors. Relay Therapeutics Inc., a clinical-stage ...
Coya Therapeutics, Inc. ( (COYA)) has released its Q3 earnings. Here is a breakdown of the information Coya Therapeutics, Inc. presented to its investors. Coya Therapeutics, Inc. is a clinical ...
Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants Lawyer raises objections to 23andMe's proposed $30 million settlement, arguing it undermines arbitration ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Vivo is reportedly gearing up to launch its latest S20 series this month in China, according to a recent leak by tipster Smart Pikachu. Following the success of the S19 series, the S20 lineup is ...
The Centers for Disease Control and Prevention typically coordinates between 17 and 36 investigations of foodborne illnesses involving multiple states each week. A report is posted weekly, but ...